Abstract
The metabolism of 7- 3H-pregnenolone was studied in vitro using 16 human breast carcinomas. All mammary tumors transformed pregnenolone to progesterone. All estrogen receptor poor tumors and 4 out of 8 estrogen receptor rich tumors converted pregnenolone to 17-hydroxypregnenolone. Five estrogen receptor poor tumors showed the presence of 17,20-lyase as evidenced by formation of dehydroepiandro-sterone and androstenedione. In two estrogen receptor poor tumors, conversions of pregnenolone to progesterone, 17-hydroxy pregnenolone, dehydroepiandrosterone androstenedione and finally to estradiol was documented, providing a hypothetical pathway for steroid metabolism in human breast cancer. The conversion of pregnenolone to 17-hydroxy-pregnenolone was significantly less in receptor rich tumors and was totally absent in 4 receptor rich tumors with estrogen receptors of over 45 fmol/mg protein.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 817-827 |
| Number of pages | 11 |
| Journal | Steroids |
| Volume | 34 |
| Issue number | 7 |
| DOIs | |
| State | Published - Dec 1979 |
Bibliographical note
Funding Information:This investigation was supported in part Grants CA 20530 and CA22467 from the National the Graduate School, University of Minnesota
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Metabolism of pregnenolone by human breast cancer. Evidence for 17α-hydroxylase and 17,20-lyase'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS